Platinum‐induced peripheral neurotoxicity (PIPN) is a common side effect of platinum‐
based chemotherapy that may cause dose reduction and discontinuation, with oxaliplatin …

Platinum compounds are widely used in the treatment of pediatric tumors such as
neuroblastoma, germ-cell tumors, osteosarcoma, retinoblastoma, hepatoblastoma, brain …

Purpose To describe the frequency and severity of ototoxicity in a series of pediatric patients
treated with platinum-based chemotherapy. Patients and Methods Serial audiologic …

The aim of this study was to determine the risk factors for high-frequency hearing loss in
children treated with cisplatin. We scored off-treatment pure-tone audiograms from 153 …

This study evaluates the degree and relevance of persisting ototoxicity after cisplatin-based
standard-dose chemotherapy for testicular cancer, with emphasis on identification of …

Objectives: The purpose of this study was to evaluate the severity of hearing loss after
cisplatin and/or carboplatin treatment in young children and to analyze its evolution and its …

A long‐term follow‐up study was carried out to assess ototoxicity in children who had been
treated for a malignant tumour with “standard dose” cisplatin (60–; 100 mg/m2 per course) …

Cisplatin has been associated with hearing damage. It is usually irreversible, bilateral, and
characterized by high-frequency sensorineural hearing loss. This study was carried out to …

Purpose: To investigate the incidence of radiation-induced ototoxicity according to the total
dose delivered to specific parts of the auditory system, fractionation, and chemotherapy …

PURPOSE: The pattern of sensorineural hearing loss (SNHL) after primary treatment for
nasopharyngeal carcinoma (NPC) was studied, and the effect of cisplatin, radiotherapy …